303 related articles for article (PubMed ID: 33775738)
1. Pain behavior in SCN9A (Nav1.7) and SCN10A (Nav1.8) mutant rodent models.
Xue Y; Chidiac C; Herault Y; Gaveriaux-Ruff C
Neurosci Lett; 2021 May; 753():135844. PubMed ID: 33775738
[TBL] [Abstract][Full Text] [Related]
2. Yield of peripheral sodium channels gene screening in pure small fibre neuropathy.
Eijkenboom I; Sopacua M; Hoeijmakers JGJ; de Greef BTA; Lindsey P; Almomani R; Marchi M; Vanoevelen J; Smeets HJM; Waxman SG; Lauria G; Merkies ISJ; Faber CG; Gerrits MM
J Neurol Neurosurg Psychiatry; 2019 Mar; 90(3):342-352. PubMed ID: 30554136
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study.
de Greef BT; Merkies IS; Geerts M; Faber CG; Hoeijmakers JG
Trials; 2016 Jun; 17(1):306. PubMed ID: 27363506
[TBL] [Abstract][Full Text] [Related]
4. [Pain and analgesia : Mutations of voltage-gated sodium channels].
Eberhardt MJ; Leffler A
Schmerz; 2017 Feb; 31(1):14-22. PubMed ID: 27402262
[TBL] [Abstract][Full Text] [Related]
5. Painful and painless channelopathies.
Bennett DL; Woods CG
Lancet Neurol; 2014 Jun; 13(6):587-99. PubMed ID: 24813307
[TBL] [Abstract][Full Text] [Related]
6. Influence of androgenic blockade with flutamide on pain behaviour and expression of the genes that encode the NaV1.7 and NaV1.8 voltage-dependent sodium channels in a rat model of postoperative pain.
Barbosa Neto JO; Garcia JBS; Cartágenes MDSS; Amaral AG; Onuchic LF; Ashmawi HA
J Transl Med; 2019 Aug; 17(1):287. PubMed ID: 31455381
[TBL] [Abstract][Full Text] [Related]
7. A gain-of-function voltage-gated sodium channel 1.8 mutation drives intense hyperexcitability of A- and C-fiber neurons.
Garrison SR; Weyer AD; Barabas ME; Beutler BA; Stucky CL
Pain; 2014 May; 155(5):896-905. PubMed ID: 24447515
[TBL] [Abstract][Full Text] [Related]
8. The G1662S NaV1.8 mutation in small fibre neuropathy: impaired inactivation underlying DRG neuron hyperexcitability.
Han C; Vasylyev D; Macala LJ; Gerrits MM; Hoeijmakers JG; Bekelaar KJ; Dib-Hajj SD; Faber CG; Merkies IS; Waxman SG
J Neurol Neurosurg Psychiatry; 2014 May; 85(5):499-505. PubMed ID: 24006052
[TBL] [Abstract][Full Text] [Related]
9. Unique electrophysiological property of a novel Nav1.7, Nav1.8, and Nav1.9 sodium channel blocker, ANP-230.
Kamei T; Kudo T; Yamane H; Ishibashi F; Takada Y; Honda S; Maezawa Y; Ikeda K; Oyamada Y
Biochem Biophys Res Commun; 2024 Aug; 721():150126. PubMed ID: 38776832
[TBL] [Abstract][Full Text] [Related]
10. Small-fiber neuropathy Nav1.8 mutation shifts activation to hyperpolarized potentials and increases excitability of dorsal root ganglion neurons.
Huang J; Yang Y; Zhao P; Gerrits MM; Hoeijmakers JG; Bekelaar K; Merkies IS; Faber CG; Dib-Hajj SD; Waxman SG
J Neurosci; 2013 Aug; 33(35):14087-97. PubMed ID: 23986244
[TBL] [Abstract][Full Text] [Related]
11. Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy.
Huang J; Han C; Estacion M; Vasylyev D; Hoeijmakers JG; Gerrits MM; Tyrrell L; Lauria G; Faber CG; Dib-Hajj SD; Merkies IS; Waxman SG;
Brain; 2014 Jun; 137(Pt 6):1627-42. PubMed ID: 24776970
[TBL] [Abstract][Full Text] [Related]
12. Increased Resurgent Sodium Currents in Nav1.8 Contribute to Nociceptive Sensory Neuron Hyperexcitability Associated with Peripheral Neuropathies.
Xiao Y; Barbosa C; Pei Z; Xie W; Strong JA; Zhang JM; Cummins TR
J Neurosci; 2019 Feb; 39(8):1539-1550. PubMed ID: 30617209
[TBL] [Abstract][Full Text] [Related]
13. Effects of SCN9A gene modification on Na+ channel and the expression of nerve growth factor in a rat model of diarrhea‑predominant irritable bowel syndrome.
Cai YY; Li C; Yan ZX; Ma N; Li FF
Mol Med Rep; 2018 Jan; 17(1):1839-1846. PubMed ID: 29138838
[TBL] [Abstract][Full Text] [Related]
14. Analgesic Effects of Topical Amitriptyline in Patients With Chemotherapy-Induced Peripheral Neuropathy: Mechanistic Insights From Studies in Mice.
Genevois AL; Ruel J; Penalba V; Hatton S; Petitfils C; Ducrocq M; Principe P; Dietrich G; Greco C; Delmas P
J Pain; 2021 Apr; 22(4):440-453. PubMed ID: 33227509
[TBL] [Abstract][Full Text] [Related]
15. Painful small fiber neuropathy with gastroparesis: A new phenotype with a novel mutation in the SCN10A gene.
Dabby R; Sadeh M; Broitman Y; Yosovich K; Dickman R; Leshinsky-Silver E
J Clin Neurosci; 2016 Apr; 26():84-8. PubMed ID: 26711856
[TBL] [Abstract][Full Text] [Related]
16. Na
McKerrall SJ; Sutherlin DP
Bioorg Med Chem Lett; 2018 Oct; 28(19):3141-3149. PubMed ID: 30139550
[TBL] [Abstract][Full Text] [Related]
17. Expression of pathogenic SCN9A mutations in the zebrafish: A model to study small-fiber neuropathy.
Eijkenboom I; Sopacua M; Otten ABC; Gerrits MM; Hoeijmakers JGJ; Waxman SG; Lombardi R; Lauria G; Merkies ISJ; Smeets HJM; Faber CG; Vanoevelen JM;
Exp Neurol; 2019 Jan; 311():257-264. PubMed ID: 30316835
[TBL] [Abstract][Full Text] [Related]
18. Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors.
Shields SD; Deng L; Reese RM; Dourado M; Tao J; Foreman O; Chang JH; Hackos DH
J Neurosci; 2018 Nov; 38(47):10180-10201. PubMed ID: 30301756
[TBL] [Abstract][Full Text] [Related]
19. Painful and painless mutations of SCN9A and SCN11A voltage-gated sodium channels.
Baker MD; Nassar MA
Pflugers Arch; 2020 Jul; 472(7):865-880. PubMed ID: 32601768
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive properties of an isoform-selective inhibitor of Nav1.7 derived from saxitoxin in mouse models of pain.
Beckley JT; Pajouhesh H; Luu G; Klas S; Delwig A; Monteleone D; Zhou X; Giuvelis D; Meng ID; Yeomans DC; Hunter JC; Mulcahy JV
Pain; 2021 Apr; 162(4):1250-1261. PubMed ID: 33086288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
